BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

275 related articles for article (PubMed ID: 11929950)

  • 1. Hormone replacement therapy and the risk of invasive epithelial ovarian cancer in Swedish women.
    Riman T; Dickman PW; Nilsson S; Correia N; Nordlinder H; Magnusson CM; Weiderpass E; Persson IR
    J Natl Cancer Inst; 2002 Apr; 94(7):497-504. PubMed ID: 11929950
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Some life-style factors and the risk of invasive epithelial ovarian cancer in Swedish women.
    Riman T; Dickman PW; Nilsson S; Nordlinder H; Magnusson CM; Persson IR
    Eur J Epidemiol; 2004; 19(11):1011-9. PubMed ID: 15648594
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Risk factors for invasive epithelial ovarian cancer: results from a Swedish case-control study.
    Riman T; Dickman PW; Nilsson S; Correia N; Nordlinder H; Magnusson CM; Persson IR
    Am J Epidemiol; 2002 Aug; 156(4):363-73. PubMed ID: 12181107
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Perineal talc exposure and epithelial ovarian cancer risk in the Central Valley of California.
    Mills PK; Riordan DG; Cress RD; Young HA
    Int J Cancer; 2004 Nov; 112(3):458-64. PubMed ID: 15382072
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Risk factors for different histological types of ovarian cancer.
    Parazzini F; Chiaffarino F; Negri E; Surace M; Benzi G; Franceschi S; Fedele L; La Vecchia C
    Int J Gynecol Cancer; 2004; 14(3):431-6. PubMed ID: 15228415
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Early pregnancy sex steroids and maternal risk of epithelial ovarian cancer.
    Schock H; Surcel HM; Zeleniuch-Jacquotte A; Grankvist K; Lakso HÅ; Fortner RT; Kaaks R; Pukkala E; Lehtinen M; Toniolo P; Lundin E
    Endocr Relat Cancer; 2014; 21(6):831-44. PubMed ID: 25270324
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association Between Menopausal Estrogen-Only Therapy and Ovarian Carcinoma Risk.
    Lee AW; Ness RB; Roman LD; Terry KL; Schildkraut JM; Chang-Claude J; Doherty JA; Menon U; Cramer DW; Gayther SA; Risch H; Gentry-Maharaj A; Goodman MT; Modugno F; Eilber U; Moysich KB; Berchuck A; Rossing MA; Jensen A; Wicklund KG; Cushing-Haugen KL; Hogdall E; Rudolph A; Thompson PJ; Wilkens LR; Kjaer SK; Carney ME; Stram DO; Ramus SJ; Wu AH; Pike MC; Pearce CL;
    Obstet Gynecol; 2016 May; 127(5):828-836. PubMed ID: 27054934
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Risk of endometrial cancer following estrogen replacement with and without progestins.
    Weiderpass E; Adami HO; Baron JA; Magnusson C; Bergström R; Lindgren A; Correia N; Persson I
    J Natl Cancer Inst; 1999 Jul; 91(13):1131-7. PubMed ID: 10393721
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Acrylamide and Glycidamide Hemoglobin Adducts and Epithelial Ovarian Cancer: A Nested Case-Control Study in Nonsmoking Postmenopausal Women from the EPIC Cohort.
    Obón-Santacana M; Lujan-Barroso L; Travis RC; Freisling H; Ferrari P; Severi G; Baglietto L; Boutron-Ruault MC; Fortner RT; Ose J; Boeing H; Menéndez V; Sánchez-Cantalejo E; Chamosa S; Castaño JM; Ardanaz E; Khaw KT; Wareham N; Merritt MA; Gunter MJ; Trichopoulou A; Papatesta EM; Klinaki E; Saieva C; Tagliabue G; Tumino R; Sacerdote C; Mattiello A; Bueno-de-Mesquita HB; Peeters PH; Onland-Moret NC; Idahl A; Lundin E; Weiderpass E; Vesper HW; Riboli E; Duell EJ
    Cancer Epidemiol Biomarkers Prev; 2016 Jan; 25(1):127-34. PubMed ID: 26598536
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Low-dose aspirin use and the risk of ovarian cancer in Denmark.
    Baandrup L; Kjaer SK; Olsen JH; Dehlendorff C; Friis S
    Ann Oncol; 2015 Apr; 26(4):787-792. PubMed ID: 25538177
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hormone replacement therapy as a risk factor for epithelial ovarian cancer: results of a case-control study.
    Hempling RE; Wong C; Piver MS; Natarajan N; Mettlin CJ
    Obstet Gynecol; 1997 Jun; 89(6):1012-6. PubMed ID: 9170483
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Epithelial Ovarian Cancer with Endometriosis is not Associated with Menopausal Status: a Co-Association Study at Prapokklao Hospital.
    Muangtan S; Suknikhom W; Sananpanichkul P; Bhamarapravatana K; Suwannarurk K
    Asian Pac J Cancer Prev; 2018 May; 19(5):1337-1341. PubMed ID: 29802696
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Risk factors for epithelial borderline ovarian tumors: results of a Swedish case-control study.
    Riman T; Dickman PW; Nilsson S; Correia N; Nordlinder H; Magnusson CM; Persson IR
    Gynecol Oncol; 2001 Dec; 83(3):575-85. PubMed ID: 11733975
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hormone replacement therapy formulations and risk of epithelial ovarian carcinoma.
    Sit AS; Modugno F; Weissfeld JL; Berga SL; Ness RB
    Gynecol Oncol; 2002 Aug; 86(2):118-23. PubMed ID: 12144815
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Anti-Müllerian hormone and risk of ovarian cancer in nine cohorts.
    Jung S; Allen N; Arslan AA; Baglietto L; Barricarte A; Brinton LA; Egleston BL; Falk RT; Fortner RT; Helzlsouer KJ; Gao Y; Idahl A; Kaaks R; Krogh V; Merritt MA; Lundin E; Onland-Moret NC; Rinaldi S; Schock H; Shu XO; Sluss PM; Staats PN; Sacerdote C; Travis RC; Tjønneland A; Trichopoulou A; Tworoger SS; Visvanathan K; Weiderpass E; Zeleniuch-Jacquotte A; Dorgan JF
    Int J Cancer; 2018 Jan; 142(2):262-270. PubMed ID: 28921520
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hormone replacement therapy and epithelial ovarian cancer: is there and association?
    Riman T
    J Br Menopause Soc; 2003 Jun; 9(2):61-8. PubMed ID: 12844427
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hormone replacement therapy and risk of epithelial ovarian cancer.
    Purdie DM; Bain CJ; Siskind V; Russell P; Hacker NF; Ward BG; Quinn MA; Green AC
    Br J Cancer; 1999 Oct; 81(3):559-63. PubMed ID: 10507786
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hormone replacement therapy and invasive and borderline epithelial ovarian cancer risk.
    Mills PK; Riordan DG; Cress RD; Goldsmith DF
    Cancer Detect Prev; 2005; 29(2):124-32. PubMed ID: 15829372
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Estrogen-progestin replacement therapy and endometrial cancer.
    Pike MC; Peters RK; Cozen W; Probst-Hensch NM; Felix JC; Wan PC; Mack TM
    J Natl Cancer Inst; 1997 Aug; 89(15):1110-6. PubMed ID: 9262248
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Population attributable fractions for ovarian cancer in Swedish women by morphological type.
    Granström C; Sundquist J; Hemminki K
    Br J Cancer; 2008 Jan; 98(1):199-205. PubMed ID: 18071361
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.